| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 4.75 mm | 4.75 mm | 4.75 mm | 4.75 mm | 4.75 mm | 4.75 mm |
| Cash burn (monthly) | 535.67 k | (no burn) | 710.00 k | 692.33 k | 756.00 k | 1.01 mm |
| Cash used (since last report) | 2.15 mm | n/a | 2.86 mm | 2.78 mm | 3.04 mm | 4.08 mm |
| Cash remaining | 2.59 mm | n/a | 1.89 mm | 1.96 mm | 1.71 mm | 666.24 k |
| Runway (months of cash) | 4.8 | n/a | 2.7 | 2.8 | 2.3 | 0.7 |
| 13F holders | Current |
|---|---|
| Total holders | 1 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 73.77 mm |
| Total shares | 204.91 k |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| TEP Biotech | 204.91 k | $73.77 mm |
| Proequities | 0.00 | $0.00 |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 23 Jan 25 | David Leslie Szekeres | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6857 | 51,937 | 35.61 k | 51,937 |
| 23 Jan 25 | Roelof Rongen | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6857 | 30,297 | 20.77 k | 30,297 |
| 23 Jan 25 | Leanne M. Kelly | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6857 | 43,319 | 29.70 k | 43,319 |
| 23 Jan 25 | Vipin Chaturvedi | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6857 | 43,319 | 29.70 k | 43,319 |
| 23 Jan 25 | Walter Marc Hertz | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6857 | 129,730 | 88.96 k | 129,730 |
